Who are Shenlingcao Oral Liquid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Tice Bcg, Pediarix, Post - Vaccination, Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis, Shensong Yangxin capsule, Low dose WenXin keli.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/shenlingcao-oral-liquid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Shenlingcao Oral Liquid — Competitive Intelligence Brief

Shenlingcao Oral Liquid (Shenlingcao Oral Liquid) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese Medicine. Area: Immunology.

marketed Traditional Chinese Medicine Immune system Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Shenlingcao Oral Liquid (Shenlingcao Oral Liquid) — West China Hospital.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Shenlingcao Oral Liquid TARGET	Shenlingcao Oral Liquid	West China Hospital	marketed	Traditional Chinese Medicine	Immune system
Tice Bcg	bcg	Pfizer	marketed	Live Attenuated Bacillus Calmette-Guerin Vaccine [EPC]	BCG targets the immune system, specifically the activation of immune cells such as T-cells and macrophages.
Pediarix	pediarix	Pfizer Inc.	marketed	vaccine	Immune system
Post - Vaccination	vaccination	Pfizer	marketed	Inactivated Poliovirus Vaccine [EPC]	Immune system
Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis	Tetanus Toxoid Reduced Diphtheria Toxoid Acellular Pertussis	Sanofi Pasteur, a Sanofi Company	marketed	Vaccine	The vaccine targets the immune system to produce antibodies against tetanus, diphtheria, and pertussis toxins.
Shensong Yangxin capsule	Shensong Yangxin capsule	kejiang Cao	marketed	Traditional Chinese medicine herbal formulation
Low dose WenXin keli	Low dose WenXin keli	Beijing Bozhiyin T&S Co., Ltd.	marketed	Traditional Chinese medicine herbal formulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese Medicine class)

West China Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Shenlingcao Oral Liquid — Competitive Intelligence Brief. https://druglandscape.com/ci/shenlingcao-oral-liquid. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab